CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing novel immunosuppressants targeting Type-1 interferon production for autoimmune and neuroinflammatory conditions. It aims to identify promising compounds with favorable properties for future therapeutic applications, paving the way for potential commercial exploitation.
Several major unmet medical needs, such as autoimmune disorders and neuroinflammatory conditions, are characterized by aberrant Type-1 interferon production, suggesting that new drugs that specifically target this central inflammatory signalling axis could provide significant value for patients and for society.
In this project, we will develop the foundation for future commercial exploitation of a class of novel macrocyclic immunosuppressants which has been shown to possess unprecedented broad i…
AARHUS UNIVERSITET
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
